Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adnexal Diseases (Phase 2)
Carcinoma (Phase 2)
Colonic Diseases (Phase 2)
Colorectal Neoplasms (Phase 2)
Digestive System Diseases (Phase 2)
Digestive System Neoplasms (Phase 2)
Endocrine Gland Neoplasms (Phase 2)
Endocrine System Diseases (Phase 2)
Female Urogenital Diseases (Phase 2)
Gastrointestinal Diseases (Phase 2)
Gastrointestinal Neoplasms (Phase 2)
Genital Diseases, Female (Phase 2)
Genital Neoplasms, Female (Phase 2)
Gonadal Disorders (Phase 2)
Intestinal Diseases (Phase 2)
Intestinal Neoplasms (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Glandular and Epithelial (Phase 2)
Ovarian Diseases (Phase 2)
Ovarian Neoplasms (Phase 2)
Rectal Diseases (Phase 2)
Urogenital Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue